Literature DB >> 12857903

Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.

Arianna Loregian1, Roberto Rigatti, Mary Murphy, Elisabetta Schievano, Giorgio Palu, Howard S Marsden.   

Abstract

In common with other herpesviruses, the human cytomegalovirus (HCMV) DNA polymerase contains a catalytic subunit (Pol or UL54) and an accessory protein (UL44) that is thought to increase the processivity of the enzyme. The observation that antisense inhibition of UL44 synthesis in HCMV-infected cells strongly inhibits viral DNA replication, together with the structural similarity predicted for the herpesvirus processivity subunits, highlights the importance of the accessory protein for virus growth and raises the possibility that the UL54/UL44 interaction might be a valid target for antiviral drugs. To investigate this possibility, overlapping peptides spanning residues 1161 to 1242 of UL54 were synthesized and tested for inhibition of the interaction between purified UL54 and UL44 proteins. A peptide, LPRRLHLEPAFLPYSVKAHECC, corresponding to residues 1221 to 1242 at the very C terminus of UL54, disrupted both the physical interaction between the two proteins and specifically inhibited the stimulation of UL54 by UL44. A mutant peptide lacking the two carboxy-terminal cysteines was markedly less inhibitory, suggesting a role for these residues in the UL54/UL44 interaction. Circular dichroism spectroscopy indicated that the UL54 C-terminal peptide can adopt a partially alpha-helical structure. Taken together, these results indicate that the two subunits of HCMV DNA polymerase most likely interact in a way which is analogous to that of the two subunits of herpes simplex virus DNA polymerase, even though there is no sequence homology in the binding site, and suggest that the UL54 peptide, or derivatives thereof, could form the basis for developing a new class of anti-HCMV inhibitors that act by disrupting the UL54/UL44 interaction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857903      PMCID: PMC165265          DOI: 10.1128/jvi.77.15.8336-8344.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis.

Authors:  C A Wu; N J Nelson; D J McGeoch; M D Challberg
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

Review 2.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

Authors:  J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  Genomic localization, sequence analysis, and transcription of the putative human cytomegalovirus DNA polymerase gene.

Authors:  R Heilbronn; G Jahn; A Bürkle; U K Freese; B Fleckenstein; H zur Hausen
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

5.  Sequence and transcription analysis of the human cytomegalovirus DNA polymerase gene.

Authors:  T Kouzarides; A T Bankier; S C Satchwell; K Weston; P Tomlinson; B G Barrell
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

Review 6.  Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.

Authors:  P Reusser
Journal:  J Hosp Infect       Date:  1996-08       Impact factor: 3.926

7.  Persistence of the alpha-helix stop signal in the S-peptide in trifluoroethanol solutions.

Authors:  J W Nelson; N R Kallenbach
Journal:  Biochemistry       Date:  1989-06-13       Impact factor: 3.162

8.  Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

Authors:  Y Matsuura; R D Possee; H A Overton; D H Bishop
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

9.  Human cytomegalovirus-associated DNA polymerase and protein kinase activities.

Authors:  E C Mar; P C Patel; E S Huang
Journal:  J Gen Virol       Date:  1981-11       Impact factor: 3.891

10.  Structure and function of the Saccharomyces cerevisiae CDC2 gene encoding the large subunit of DNA polymerase III.

Authors:  A Boulet; M Simon; G Faye; G A Bauer; P M Burgers
Journal:  EMBO J       Date:  1989-06       Impact factor: 11.598

View more
  18 in total

1.  Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44.

Authors:  Arianna Loregian; Brent A Appleton; James M Hogle; Donald M Coen
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit.

Authors:  Arianna Loregian; Brent A Appleton; James M Hogle; Donald M Coen
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Characterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54.

Authors:  Frédéric Picard-Jean; Isabelle Bougie; Martin Bisaillon
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

4.  Cloning, expression, and functional characterization of the equine herpesvirus 1 DNA polymerase and its accessory subunit.

Authors:  Arianna Loregian; Alessandro Case; Enrico Cancellotti; Carlo Valente; Howard S Marsden; Giorgio Palù
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.

Authors:  Egor P Tchesnokov; Aleksandr Obikhod; Raymond F Schinazi; Matthias Götte
Journal:  J Biol Chem       Date:  2009-07-21       Impact factor: 5.157

6.  The crystal structure of PF-8, the DNA polymerase accessory subunit from Kaposi's sarcoma-associated herpesvirus.

Authors:  Jennifer L Baltz; David J Filman; Mihai Ciustea; Janice Elaine Y Silverman; Catherine L Lautenschlager; Donald M Coen; Robert P Ricciardi; James M Hogle
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

Review 7.  Cytomegalovirus antivirals and development of improved animal models.

Authors:  Alistair McGregor; K Yeon Choi
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-09-01       Impact factor: 4.481

8.  A Small Covalent Allosteric Inhibitor of Human Cytomegalovirus DNA Polymerase Subunit Interactions.

Authors:  Han Chen; Molly Coseno; Scott B Ficarro; My Sam Mansueto; Gloria Komazin-Meredith; Sandrine Boissel; David J Filman; Jarrod A Marto; James M Hogle; Donald M Coen
Journal:  ACS Infect Dis       Date:  2016-12-06       Impact factor: 5.084

9.  Identification of human cytomegalovirus UL84 virus- and cell-encoded binding partners by using proteomics analysis.

Authors:  Yang Gao; Kelly Colletti; Gregory S Pari
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  Analysis of the association of the human cytomegalovirus DNA polymerase subunit UL44 with the viral DNA replication factor UL84.

Authors:  Blair L Strang; Elisa Sinigalia; Laurie A Silva; Donald M Coen; Arianna Loregian
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.